awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38401664-018A0EE2-1BC7-4D0B-BF50-9136D39E4CBA
Q38401664-018A0EE2-1BC7-4D0B-BF50-9136D39E4CBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38401664-018A0EE2-1BC7-4D0B-BF50-9136D39E4CBA
Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.
P2860
Q38401664-018A0EE2-1BC7-4D0B-BF50-9136D39E4CBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38401664-018A0EE2-1BC7-4D0B-BF50-9136D39E4CBA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3c198abf554f737335775d6c2dd1eede2ad1c6e
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.